the use of adjuvants in pain management stewart w. stein, m.d. medical director, good shepherd...

61
The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Upload: arleen-parks

Post on 05-Jan-2016

224 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

The Use Of Adjuvants In

Pain Management

Stewart W. Stein, M.D.Medical Director, Good Shepherd Hospice

Page 2: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Objectives• Understand basic principles of pain

transmission

• Understand the role of adjuvants in the management of pain

• Understand advantages and disadvantages of various agents in the management of chronic pain

• Understand the use of other modalities in pain management.

Page 3: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

3

Ascending Pathways

• A-delta fibers are myelinated (insulated with a myelin sheath). The pain is fast and well localized, like the initial prick or stinging sensation following an injury.

• C fibers are nonmyelinated and smaller than A-delta fibers. They transmit pain much slower. The pain is more lasting, generalized and described as a dull ache.

Page 4: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Ascending Pathways

• After afferent A-delta (myelinated and fast) and C-fibers (unmyelinated and slow) synapse with the interneurons.

• These cross over to the contralateral side and ascend primarily via the spinothalamic tracts to the thalmus and cortex.

Page 5: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

5

Ascending Pathways

Page 6: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Pathophysiology

• Nociceptor activation / Types of receptors:• Mechanical• Thermal• Chemical

• Respond to stimuli that approach or exceed harmful intensity by undergoing conformational, electrical and biochemical changes

Page 7: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

7

WHO Pain Ladder

Page 8: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

• Adjuvant Analgesics

Page 9: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Adjuvant Analgesics

• “Non-opioids with analgesic efficacy”

• Primarily used to treat neuropathic pain syndromes although also effective in management of nociceptive pain when used as adjuvants to other medications

Page 10: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Adjuvant AnalgesicsStep 1 Agents on the WHO ladder

• Non-steroidal anti-inflammatories (NSAIDS)

• Antidepressants (TCA’s)

• Anticonvulsants / Antiepileptics (AED’s)

• Cortisteroids

• Bisphosphonates

• Anesthetics

• N-Methyl D-aspartate antagonists (NMDA)

Page 11: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Acetaminophen / Paracetamol• Mechanism of action unclear but may

inhibit cyclooxygenase in the CNS

• Acetaminophen can cause liver damage if dose exceeds 4 grams a day

• Risk of hepatic injury is increased in patients having pre-existing liver damage (alcoholism, hepatitis)

• Acetaminophen has also been shown to cause renal damage.

Page 12: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

NSAIDS • Mechanism of action is the inhibition of

cyclooxygenase to decrease prostaglandin synthesis

• May have central action at the spinal cord level

• They do have a ceiling effect• Tolerance and physical dependence is NOT

seen!• Can be associated with end-organ toxicity

Page 13: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Neuropathic Pain SyndromesTrigeminal neuralgiaPost-herpetic neuralgiaDiabetic neuropathyChemotherapy-induced neuropathyPlexopathiesPhantom limb painComplex regional pain syndromeCentral post-stroke (damage to thalamus, cortical

or subcortical structures) SyringomyeliaSympathetically maintained pain syndrome (RSD)

Page 14: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Adjuvant Analgesics

• Tricyclic Anti-depressants• Inhibit reuptake of norepinephrine and

serotonin in nerve endings in the spinal cord and in the brain

• NMDA antagonism

Page 15: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Antidepressants

• Tricyclic Antidepressants• Tertiary amines:

• amitriptyline• doxepin• imipramine• clomipramine

• Secondary amines:• desipramine• nortriptyline

Page 16: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Antidepressants

• Serotoninergic agents• Fluoxetine• Paroxetine• Sertraline• Citalopram• Escitalopram

Page 17: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Antidepressants

• SNRI’s (serotonin / norepinephrine reuptake inhibitors)• Venlafaxine• Desvenlafaxine• Duloxetine

Page 18: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Antidepressants

• Used for:• Analgesia• Depression• Insomnia• (even pruritis)

Page 19: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Antidepressants:

• Mechanism of action is inhibition of reuptake of neurotransmitters (serotonin, norepinephrine and dopamine)

• Only tricyclic antidepressants have analgesic properties independent of their antidepressant activity

Page 20: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Antidepressants:Side Effects

• Nausea

• Sedation

• Confusion

• Xerostomia

• Tachycardia

• Drug interactions

• (Anticholinergic )

Page 21: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Side Effects of TCA’s

?MI

• Long term use of TCA’s is associated with a 2.2 relative risk of myocardial infarction and a 1.7fold increase in mortality vs. placebo or SSRI’s. (screen elderly with EKG?)

• American Journal of Medicine (2000) Jan;108(1):2-8

• European Heart Journal (2004) 25 (1): 3-9

Page 22: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

AED’s(Antiepileptic Drugs)

Page 23: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Mechanism of action of AED’s:

• Slow recovery of voltage gated Na channels from depolarization (carbamazepine, phenytoin)

• Indirect or direct enhancement of inhibitory Gama-aminobutyric acid neurotransmission (Valproic acid, Tiagabine)

• Inhibition of excitatory glutamatergic neurotransmission (lamotrigine)

Page 24: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Mechanism of action of AED’s

• Block voltage dependent Ca++ channel (Gabapentin and Pregabalin)

• Carbonic anhydrase inhibition (Topiramate, Zonisamide)

Page 25: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

25

Mechanism of action of AED’s:

Page 26: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

New AED’s (Anti-Epileptic Drugs)

• Gabapentin

• Topiramate

• Levitiracetam

• Tiagabine

• Oxcarbazepine

• Lamotrigine

• Felbamate

• Pregabalin

Page 27: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Use of AED’s:

• Start with a low evening dose

• Increase GRADUALLY over 4-6 weeks depending on response. (Typically effective at higher doses)

Page 28: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

New AED’sSide Effects

• Drowsiness

• Unsteadiness

• Aplastic anemia (CB)

• Dizziness

• Confusion

• Rash (VPA)

• Ataxia

• Nausea and vomiting

Page 29: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Gabapentin

• Established efficacy in treatment of post herpetic neuralgia

• Most common mistake is failure to titrate to effective doses (900mg ineffective in managing PDN in one series)

Page 30: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Gabapentin• Titration Schedule:

• Day 1: 300mg po at HS• Day 2: 300mg po bid• Day 3: 300mg po tid

• Titrate 100-300mg per day over next 2 weeks to target dose of 1800mg. Continue titration over 2 more weeks to 3600mg if indicated for effect. Higher doses have also been successfully used.

Page 31: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Pregabalin

• Advantages include predictable absorption across the GI tract. Not metabolized or protein-bound. Minimal drug-drug interactions.

• Multiple studies demonstrate effective pain relief and decreased sleep interference in PHN and PDN

Page 32: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Pregabalin

• Dosing schedule• Days 1-3: 50mg po tid• Days 4-7: 100mg po tid• Thereafter 200mg po tid.

• Taper dose over 7 days to discontinue

Page 33: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Lamotrigine

• Demonstrated efficacy in trigeminal neuralgia.

• Utility in vascular HA’s and PDN suggested by open label studies

Page 34: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Lamotrigine

• Dosing:• Start at 25-50mg po daily• Increase by 50mg per day per week until

effective or an arbitrary maximum is reached (usually around 900mg daily in 2-3 divided doses)

Page 35: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Topiramate• Studies demonstrate utility in management

of cluster headache and diabetic neuropathy

• Effective dose range is 200-400mg daily in divided (2) doses

• Associated with weight loss

• Side effects may include abnormal thinking, delusional and psychotic thinking, kidney stones.

Page 36: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Carbamazepine

• Used in trigeminal neuralgia since the 1960’s!

• Starting dose is 200mg po bid. Effective dose is usually 400-1000mg per day.

• Induces P450 system so potential for drug-drug interactions.

• Aplastic anemia occurs in 1:200,000. More commonly, a reversible leukopenia or thrombocytopenia may occur.

Page 37: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Oxcarbazepine

• An analog of carbamazepine that retains many therapeutic properties of the drug while avoiding toxicities. (No bone marrow suppression or induction of P450 system)

• Start with 300mg at HS. Increase weekly by 300-600mg until effective up to a maximum of 1200-2400mg per day.

Page 38: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Phenytoin

• Mixed results in trials (1970’s) for PDN.

• Usual dose 200-400mg po daily

• Side effects include nausea, diplopia, dizziness, confusion, gingival hyperplasia and rarely Stevens-Johnson syndrome.

• Induces P450 cytochrome system

Page 39: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Valproic acid

• Demonstrated efficacy in migraine HA’s.

• Side effects include nausea, vomiting, sedation, rash, ataxia and appetite stimulation

• 40% develop increased transaminases.

• 1:50,000 will develop HEPATIC FAILURE

Page 40: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Also part of the equation ….

• NNT: The number of patients that need to be treated with a particular drug in order for one patient to experience a 50% reduction in pain

• NNH: The number of patients that need to be treated with a particular drug in order for one patient to drop out due to adverse effects

Page 41: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

TCA (amitriptyline)

• NNT = 2-3

• NNH = 14.7

Page 42: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

AED (gabapentin)

• NNT = 5.1 (Includes all doses, high and low)

• NNH = 26.1

Page 43: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Opioids

• Morphine NNT = 2.5

• Oxycodone NNT = 2.6

• Tramadol NNT = 3.9

• NNH for tramadol = 9.0

• NNH morphine and oxycodone = not significant

Page 44: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Bisphosphonates

• Pamidronate and Zolendronic acid

• Localize to bone and inhibit osteoclastic activity

• Widely studied in treatment of metastatic bone pain

• Risk of osteonecrosis of the mandible.

Page 45: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Corticosteroids

• Inhibit arachodonic acid (prostaglandin synthesis) resulting in anti-infalmmatory action

• Also a membrane stabilizer (blocking c-fiber transmission)

Page 46: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

NMDA Receptors

• Located mostly in the dorsal horn of the spinal cord

• Activated by chronic, painful stimulus leading to allodynia, hyperalgesia, and neuropathic pain.

• Also responsible for opioid tolerance.

Page 47: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Therefore:

• Blocking NMDA results not only in improved pain control but also reverses opioid tolerance to varying degrees.

Page 48: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

NMDA receptor antagonists:

• Methadone

• Ketamine

• Dextromethorphan

Page 49: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Ketamine

• Useful in refractory neuropathic pain states

• Useful to “reset” opioid sensitivity in an opioid-tolerant patient

• Also very useful for procedures such as painful wound care

Page 50: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Neuropathic pain:How do we proceed?

• If we were to look only at pain relief, the order would be:TCAopioidstramadolgabapentin / pregabalin (recall NNT)

Page 51: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

BUT….

• If criteria are to be both relief of pain AND quality of life, the order would be:Gabapentin / pregabalinTramadolOpioidsTCA’s

Page 52: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Nerve Blocks:Celiac Plexus Block

• Used with upper abdominal malignancies

• Variable benefit

• (alcohol neurolysis most common)

Page 53: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Nerve Blocks:Mandibular / Maxillary / Gasserian ganglion block

• Used in head and neck cancer pain. Phenol / alcohol used for neurolysis

• Radiofrequency ablation also used

• Post neurolytic dysesthesia can occur

Page 54: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Axial therapy

• Both presynaptic and post synaptic opioid receptors within the dorsal horns of the spinal matter inhibit synaptic transmission from the peripheral afferent nociceptor to the second order spinal neuron.

Page 55: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Axial Therapy

• Intrathecal• subarachnoid

• Epidural• requires 10 times the intrathecal volume to

spread medication over several dermatomal segments

Page 56: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Axial Therapy

• Advantages: • Effective• Markedly reduced side effects.

• Disadvantages: • Surgical procedure• Infection• CSF leak

Page 57: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Axial vs. Oral Opiate Dosing

• Oral morphine = 300mg

• IV morphine = 100mg

• Epidural = 10mg morphine

• Intrathecal = 1mg morphine

Page 58: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Other Modalities

Vertebroplasty• Cement (polymethyl methacrylate) is injected

into the damaged vertebra and acts as an internal splint. Useful in osteoporosis and cancer-associated fractures

Page 59: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Other Modalities

• TENS• Stimulates large “A” fibers that then close the

gate for pain coming in from “C” fibers. Used in acute and chronic pain syndromes.

• Low intensity: not reversed by naloxone

• High intensity: reversed by naloxone

Page 60: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Other Modalities

• Acupuncture: Possibly acts on reward center (dopamine and serotonin)

• May increase muscle blood flow

• May reduce gastric acid and correct gastric arrhythmia, thereby reducing nausea and vomiting.

Page 61: The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice

Questions Questions & Comments& Comments